Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Cigna Group (NYSE:CI - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 405,247 shares of the health services provider's stock, valued at approximately $111,718,000. Connor Clark & Lunn Investment Management Ltd. owned 0.15% of Cigna Group as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Brighton Jones LLC lifted its position in Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock worth $1,032,000 after acquiring an additional 318 shares during the last quarter. Sivia Capital Partners LLC grew its position in shares of Cigna Group by 10.4% in the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider's stock valued at $384,000 after purchasing an additional 109 shares during the last quarter. NewEdge Advisors LLC increased its stake in shares of Cigna Group by 4.5% during the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider's stock worth $7,347,000 after purchasing an additional 958 shares during the period. Treasurer of the State of North Carolina lifted its holdings in Cigna Group by 16.6% during the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider's stock worth $49,204,000 after purchasing an additional 21,173 shares during the last quarter. Finally, Osterweis Capital Management Inc. acquired a new position in Cigna Group in the 2nd quarter valued at $163,000. Institutional investors and hedge funds own 86.99% of the company's stock.
Analysts Set New Price Targets
A number of research firms have recently weighed in on CI. The Goldman Sachs Group lifted their target price on Cigna Group from $335.00 to $340.00 and gave the stock a "buy" rating in a report on Monday, May 4th. Raymond James Financial cut shares of Cigna Group from a "strong-buy" rating to an "outperform" rating and lowered their target price for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. UBS Group increased their price target on Cigna Group from $375.00 to $400.00 and gave the stock a "buy" rating in a research report on Friday, May 22nd. Wall Street Zen cut Cigna Group from a "buy" rating to a "hold" rating in a report on Saturday, August 1st. Finally, Sanford C. Bernstein increased their target price on Cigna Group from $371.00 to $381.00 and gave the stock an "outperform" rating in a report on Thursday, July 9th. Fifteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. According to data from MarketBeat, Cigna Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $339.45.
View Our Latest Research Report on Cigna Group
Insider Buying and Selling
In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the business's stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company's stock, valued at $707,108.48. The trade was a 27.52% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Nicole S. Jones sold 19,436 shares of the company's stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares of the company's stock, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 23,012 shares of company stock valued at $6,386,550. 0.60% of the stock is owned by company insiders.
Cigna Group Trading Down 0.5%
Shares of CI stock opened at $276.19 on Monday. The firm has a market capitalization of $72.98 billion, a P/E ratio of 11.43, a P/E/G ratio of 0.95 and a beta of 0.29. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock's fifty day simple moving average is $284.20 and its 200 day simple moving average is $281.45.
Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same period last year, the company earned $7.20 earnings per share. The business's quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts predict that Cigna Group will post 30.51 EPS for the current fiscal year.
Cigna Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Tuesday, September 8th. Cigna Group's dividend payout ratio (DPR) is 25.82%.
About Cigna Group
(
Free Report)
Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Further Reading
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
